# Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward

> **NCT04871958** · NA · TERMINATED · sponsor: **Federico II University** · enrollment: 66 (actual)

## Conditions studied

- Diabetes Mellitus
- Covid19

## Interventions

- **DEVICE:** Continuous glucose monitoring (CGM, Dexcom G6)

## Key facts

- **NCT ID:** NCT04871958
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-19
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 66 (ACTUAL)
- **Why stopped:** Shift of the participating wards to non-Covid patients
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04871958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04871958, "Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04871958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*